Login / Signup

Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial.

Flora ZagouriGeorgia-Angeliki KoliouFoteinos DimitrakopoulosChristos PapadimitriouIoannis BinasAngelos KoutrasPavlos PapakostasChristos MarkopoulosVasileios VenizelosGrigorios XepapadakisΑngeliki AndrikopoulouCharisios KaranikiotisAmanda PsyrriDimitrios BafaloukosParis KosmidisGerasimos AravantinosEleni ResDavide MauriAnna KoumarianouKalliopi PetrakiAnna TsipouraDimitrios PectasidesHelen GogasGeorge Fountzilas
Published in: British journal of cancer (2022)
Australian New Zealand Clinical Trials Registry ACTRN12610000151033.
Keyphrases
  • phase iii
  • clinical trial
  • open label
  • phase ii
  • palliative care
  • double blind
  • epidermal growth factor receptor
  • placebo controlled
  • metastatic breast cancer
  • study protocol
  • randomized controlled trial
  • tyrosine kinase